SCHEMBL22952930

SCHEMBL22952930

Oc1ccc2c(c1O)CC(c1ccncc1)C1CCNCC21

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.78
DRD2 P14416 1/20 0.78
ADRA2B P18089 1/20 0.78
ADRA2C P18825 1/20 0.78
DRD1 P21728 1/20 0.78
DRD5 P21918 1/20 0.78
DRD3 P35462 1/20 0.78
CYP19A1 P11511 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP1A1 P04798 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2E1 P05181 1/20 0.36
CYP2C8 P10632 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2A6 P11509 1/20 0.36
CYP2C9 P11712 1/20 0.36
CYP4B1 P13584 1/20 0.36
CYP2B6 P20813 1/20 0.36
CYP3A5 P20815 1/20 0.36
CYP2A7 P20853 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL611683 0.88 DRD1 (1.00) ADRA2ADRD2ADRA2BADRA2CDRD1
SCHEMBL22952932 0.86 ADRA2A (0.68) ADRA2ADRD2ADRA2BADRA2CDRD1
SCHEMBL22952996 0.84 DRD1 (0.65) ADRA2ADRD2ADRA2BADRA2CDRD1
SCHEMBL22952992 0.84 DRD1 (0.65) ADRA2ADRD2ADRA2BADRA2CDRD1
SCHEMBL22952994 0.84 ADRA2A (0.65) ADRA2ADRD2ADRA2BADRA2CDRD1
SCHEMBL22953002 0.84 ADRA2A (0.65) ADRA2ADRD2ADRA2BADRA2CDRD1
SCHEMBL22952936 0.82 DRD1 (0.63) ADRA2ADRD2ADRA2BADRA2CDRD1
SCHEMBL22952935 0.82 DRD1 (0.54) ADRA2ADRD2ADRA2BADRA2CDRD1
SCHEMBL22952993 0.82 ADRA2A (0.62) ADRA2ADRD2ADRA2BADRA2CDRD1
SCHEMBL22953000 0.76 ADRA2A (0.49) ADRA2ADRD2ADRA2BADRA2CDRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021021922-A1 COMPOUNDS AND METHODS FOR TREATING FIBROTIC PATHOLOGIES MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2021-02-04 WO disclosed